NATURE’S SUNSHINE PRODUCTS, INC. Shipping and Handling Revenue (Deprecated 2018-01-31)
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Shipping and Handling Revenue (Deprecated 2018-01-31) of $8.20 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Income Statement › Other Income
us-gaap:ShippingAndHandlingRevenue · last filed 2018-03-16
- NATURE’S SUNSHINE PRODUCTS, INC. shipping and handling revenue (deprecated 2018-01-31) for fiscal 2017 was $8.20M, a 10.87% decline from fiscal 2016.
- NATURE’S SUNSHINE PRODUCTS, INC. shipping and handling revenue (deprecated 2018-01-31) for fiscal 2016 was $9.20M, a 0.00% change from fiscal 2015.
- NATURE’S SUNSHINE PRODUCTS, INC. shipping and handling revenue (deprecated 2018-01-31) for fiscal 2015 was $9.20M, a 6.12% decline from fiscal 2014.
- NATURE’S SUNSHINE PRODUCTS, INC. shipping and handling revenue (deprecated 2018-01-31) for fiscal 2014 was $9.80M, a 10.09% decline from fiscal 2013.
| Period end | Shipping and Handling Revenue (Deprecated 2018-01-31) 12 month | Shipping and Handling Revenue (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|
| 2017-12-31 | $8.20M 10-K · filed 2018-03-16 | |
| 2016-12-31 | $9.20M 10-K · filed 2018-03-16 | |
| 2015-12-31 | $9.20M 10-K · filed 2018-03-16 | |
| 2014-12-31 | $9.80M 10-K · filed 2017-03-14 | $9.79M 10-K · filed 2015-03-13 |
| 2013-12-31 | $10.90M 10-K · filed 2016-03-14 | $10.87M 10-K · filed 2014-03-17 |
| 2012-12-31 | $11.26M 10-K · filed 2015-03-13 | |
| 2011-12-31 | $11.62M 10-K · filed 2014-03-17 | |
| 2010-12-31 | $12.16M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |